CJC open · 2026
Socioeconomic Burden of Pulmonary Arterial Hypertension in Patients and Caregivers: A Canadian Cross-Sectional Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Budhram Brandon, Myrah Jamie, Westerhout Cynthia M, Gubbels Courtney, Alemayehu Wendimagegn, Budd Evelyn, Abraham Theodore, Weatherald Jason
Аннотация
BACKGROUND: Pulmonary arterial hypertension (PAH) is a serious condition that can impair daily functioning, employment, and quality of life for working-age individuals. We evaluated the real-world socioeconomic burden of PAH on patients and their caregivers.
METHODS: We conducted a cross-sectional survey of adult Canadian patients between August15, 2023 and October 9, 2023. Using the Work Productivity and Activity Impairment Questionnaire, the EQ-5D Visual Analogue Scale, and additional survey items, we assessed employment status, work limitations, changes in work patterns, quality of life, and perceived caregiver burden. Predictors of employment were identified using multivariate logistic regression.
RESULTS: Among 217 participants, 61 (28%) were employed. Working participants reported high presenteeism-that is, impairment while working, due to PAH (50%, interquartile range [IQR] 10, 70). Older age (odds ratio [OR] 0.62, 95% confidence interval [CI] 0.54-0.72, P < 0.001), worse functional class (III-IV compared to I-II; OR 0.38, 95% CI 0.17-0.82, P = 0.014), increased time from PAH diagnosis (OR 0.72, 95% CI 0.54-0.95, P = 0.022), and parenteral prostanoids (OR 0.30, 95% CI 0.09-1.00, P = 0.050) were associated with lower odds of employment, while being in a living-together relationship (OR 3.58, 95% CI 1.40-9.17, P = 0.008) was associated with being employed. Caregiver support was required by 92 patients (45%), with caregivers contributing a perceived median of 15 hours (IQR 6, 35) per week and losing an estimated 4 hours (IQR 0, 10) of potential work hours per week.
CONCLUSIONS: PAH imposes a substantial socioeconomic burden on patients and caregivers. Patients with PAH experience low rates of employment, high presenteeism, and significant caregiver work loss. These findings highlight an underrecognized aspect of PAH care.
METHODS: We conducted a cross-sectional survey of adult Canadian patients between August15, 2023 and October 9, 2023. Using the Work Productivity and Activity Impairment Questionnaire, the EQ-5D Visual Analogue Scale, and additional survey items, we assessed employment status, work limitations, changes in work patterns, quality of life, and perceived caregiver burden. Predictors of employment were identified using multivariate logistic regression.
RESULTS: Among 217 participants, 61 (28%) were employed. Working participants reported high presenteeism-that is, impairment while working, due to PAH (50%, interquartile range [IQR] 10, 70). Older age (odds ratio [OR] 0.62, 95% confidence interval [CI] 0.54-0.72, P < 0.001), worse functional class (III-IV compared to I-II; OR 0.38, 95% CI 0.17-0.82, P = 0.014), increased time from PAH diagnosis (OR 0.72, 95% CI 0.54-0.95, P = 0.022), and parenteral prostanoids (OR 0.30, 95% CI 0.09-1.00, P = 0.050) were associated with lower odds of employment, while being in a living-together relationship (OR 3.58, 95% CI 1.40-9.17, P = 0.008) was associated with being employed. Caregiver support was required by 92 patients (45%), with caregivers contributing a perceived median of 15 hours (IQR 6, 35) per week and losing an estimated 4 hours (IQR 0, 10) of potential work hours per week.
CONCLUSIONS: PAH imposes a substantial socioeconomic burden on patients and caregivers. Patients with PAH experience low rates of employment, high presenteeism, and significant caregiver work loss. These findings highlight an underrecognized aspect of PAH care.